VEGF‐A production by tumor cells is associated with a poor prognosis; however, deletion of the HIF target gene VEGF‐A in CD8+ T cells accelerated tumorigenesis and altered angiogenesis. The gene discussed is VEGFA; the disease is neoplasm.